Furthermore, western blot results showed that HIF-1α expression was obviously inhibited in ALL cells treated with DFO, and PHD-2 expression was significantly increased, whereas Dex reversed those effects of DFO (Figures 4(c) and 4(d)). The gene discussed is EGLN1; the disease is acute lymphoblastic leukemia.